Regennova
Pioneering the future of medicine for inflammatory and neurological challenges like Cerebral Stroke, Traumatic Brain Injury, and Alzheimer's disease.
Pioneering the future of medicine for inflammatory and neurological challenges like Cerebral Stroke, Traumatic Brain Injury, and Alzheimer's disease.
Regennova, a biotech startup founded in 2022, is pioneering the future of medicine for inflammatory and neurological challenges such as Cerebral Stroke, Traumatic Brain Injury, and Alzheimer's disease. The company's dedication to developing innovative medicines for these illnesses has attracted the attention of investors, with First Flight Venture Center providing a $5.00K grant investment on 10 August 2022. Regennova operates in the Biopharma and Biotechnology industries, positioning itself at the forefront of medical innovation. With its focus on addressing critical medical needs, Regennova presents a promising prospect for venture capitalists seeking to support the advancement of healthcare solutions.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $5.00K | 1 |
|
10 Aug 2022 |
No recent news or press coverage available for Regennova.
We care about your data, and we'd love to use cookies make your experience better.